Cipla’s arm inks definitive agreements to acquire Endura Mass

15 Jul 2022 Evaluate

Cipla’s wholly owned subsidiary and consumer healthcare arm -- Cipla Health (CHL) has signed definitive agreements for acquisition of Endura Mass, a renowned nutritional supplement brand in the category of weight gain from Medinnbelle Herbalcare. Endura and all other associated trademarks would be part of the acquisition.

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset. As per the signed definitive agreements, acquisition is subject to completion of certain closing conditions. CHL shall immediately initiate the distribution and marketing of the said products pending the closure of the proposed acquisition.

As per the Lancet Journal (Study from 1975 - 2014), India has approximately 20 crore adult (male & female) population who are underweight. Endura Mass has a legacy of over 20 years in providing solutions for consumers actively looking to gain weight. It has a range of proven, efficacious, and safe range of weight gainers that help to gain weight in a healthy way.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1509.20 9.10 (0.61%)
02-Jan-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.00
Dr. Reddys Lab 1254.00
Cipla 1509.20
Zydus Lifesciences 915.45
Lupin 2105.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×